Kyle B Stephenson

Kyle B Stephenson

UNVERIFIED PROFILE

Are you Kyle B Stephenson?   Register this Author

Register author
Kyle B Stephenson

Kyle B Stephenson

Publications by authors named "Kyle B Stephenson"

Are you Kyle B Stephenson?   Register this Author

16Publications

456Reads

10Profile Views

Measles Vaccines Designed for Enhanced CD8 T Cell Activation.

Viruses 2020 Feb 21;12(2). Epub 2020 Feb 21.

National Center for Tumor Diseases (NCT), Department of Medical Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/v12020242DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077255PMC
February 2020

Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer.

Vaccine 2018 04 12;36(16):2181-2192. Epub 2018 Mar 12.

McMaster Immunology Research Centre, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada; Turnstone Biologics, Ottawa, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0264410X183025
Publisher Site
http://dx.doi.org/10.1016/j.vaccine.2018.02.070DOI Listing
April 2018

Customized Viral Immunotherapy for HPV-Associated Cancer.

Cancer Immunol Res 2017 10 14;5(10):847-859. Epub 2017 Sep 14.

McMaster Immunology Research Centre, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0102DOI Listing
October 2017

Maraba virus as a potent oncolytic vaccine vector.

Mol Ther 2014 Feb 25;22(2):420-429. Epub 2013 Oct 25.

McMaster Immunology Research Center, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2013.249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916044PMC
February 2014

Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-κB activation.

J Virol 2014 Jan 9;88(1):54-65. Epub 2013 Oct 9.

McMaster Immunology Research Centre, Department of Pathology & Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.02678-13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911702PMC
January 2014

IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells.

Cancer Res 2011 Apr 9;71(7):2497-506. Epub 2011 Feb 9.

Department of Pathology and Molecular Medicine and Medical Sciences Program, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-10-3025DOI Listing
April 2011

Potentiating cancer immunotherapy using an oncolytic virus.

Mol Ther 2010 Aug 15;18(8):1430-9. Epub 2010 Jun 15.

Centre for Gene Therapeutics, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2010.98DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927075PMC
August 2010

The p14 FAST protein of reptilian reovirus increases vesicular stomatitis virus neuropathogenesis.

J Virol 2009 Jan 29;83(2):552-61. Epub 2008 Oct 29.

Department of Microbiology and Immunology, Ottawa Health Research Institute, University of Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.01921-08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612406PMC
January 2009